-
Transitions of care have been a bugaboo of medicine for years. And the problem isn’t getting easier. With accountable care organizations and the increased emphasis on various spokes of the healthcare wheel being able to talk clearly across the radius to each other, it has become more and more important to find simple, proven ways to ensure that handing a patient from one part of the system to the other happens quickly, yet with all the pertinent information.
-
It’s one of those cases where the focus is distinctly on the cup half-full: More than 1,200 hospitals, or just about 37% of those accredited by The Joint Commission, achieved Top Performer status on 2013 accountability measure data. That’s an increase of more than 11% from last year. This is good. But it still means that just about two-thirds of the hospitals The Joint Commission accredits don’t meet that mark.
-
-
If you look at the previous iterations of ECRI Institute’s top 10 tech hazards lists, you will see some items that seem to make the list every year.
-
There is nobody who walks the path to the NIST Malcolm Baldrige Quality Excellence award and calls it a sprint. It is something deliberately undertaken with some knowledge that it will be a matter of years before you have any real chance of being one of the organizations named a winner.
-
-
Federal regulations require researchers to maintain an equitable selection of participants, and IRBs take this into consideration when reviewing study protocols. But what are the ethical implications when a study has difficulty recruiting or retaining subjects? From an IRB perspective, recruitment must not be coercive, but how can researchers ensure participants are truly willing volunteers in small studies that require a major physical commitment?
-
Its a long-standing issue with IRBs: Studies are approved, participants are enrolled, study interventions and visits occur and someone complains. But then what?
-
IRB Advisor asked Diana T. Chingos, MS, MFA, executive director of the Noreen Fraser Foundation in Los Angeles, to tell readers a little more about herself and her hopes and goals for the Secretarys Advisory Committee on Human Research Protections (SACHRP), to which she was appointed in October 2014.
-
Blogs, message boards, and patient communities are being used not only by patients, but also by research participants. In some cases, this reveals whether or not a participant is taking actual medication or placebos, compromising the studys validity.
